Notably, cellular depletion of TDP2 results in increased sensitivity to etoposide-induced DSBs (Cortes Ledesma et al., 2009[12]) and raises the possibility that TTRAP/TDP2 plays a role in cancer development and response to therapeutic treatments. The gene discussed is TDP2; the disease is cancer.